 |
|
|
REFERENCES
1.
Eger EI II: Uptake of inhaled anesthetics: The
alveolar to inspired anesthetic difference. In Eger
EI II: Anesthetic Uptake and Action. Baltimore, Williams & Wilkins, 1974, pp.
77–96.
2.
Eger EI II: Partition coefficients of I-653 in
human blood, saline, and olive oil. Anesth Analg 66:971–973, 1987.
3.
Eger RR, Eger EI II: Effect of temperature and
age on the solubility of enflurane, halothane, isoflurane and methoxyflurane in human
blood. Anesth Analg 64:640–642, 1985.
4.
Eger EI II, Shargel RO, Merkel G: Solubility of
diethyl ether in water, blood and oil. Anesthesiology 24:676–678, 1963.
5.
Eger EI II, Shargel R: The solubility of methoxyflurane
in human blood and tissue homogenates. Anesthesiology 24:625–627, 1963.
6.
Cromwell TH, Eger EI II, Stevens WC, Dolan WM:
Forane uptake, excretion and blood solubility in man. Anesthesiology 35:401–408,
1971.
7.
Yasuda N, Targ AG, Eger EI II: Solubility of I-653,
sevoflurane, isoflurane, and halothane in human tissues. Anesth Analg 69:370–373,
1989.
8.
Lerman J, Schmitt-Bantel BI, Gregory GA, et al:
Effect of age on the solubility of volatile anesthetics in human tissues. Anesthesiology
65:307–311, 1986.
9.
Bacher A, Burton AW, Uchida T, Zornow MH: Sevoflurane
or halothane anesthesia: Can we tell the difference? Anesth Analg 85:1203–1206,
1997.
10.
Munson ES, Eger EI II, Bowers DL: Effects of anesthetic-depressed
ventilation and cardiac output on anesthetic uptake. Anesthesiology 38:251–259,
1973.
11.
Yasuda N, Lockhart SH, Eger EI II, et al: Kinetics
of desflurane, isoflurane, and halothane in humans. Anesthesiology 74:489–498,
1991.
12.
Yasuda N, Lockhart SH, Eger EI II, et al: Comparison
of kinetics of sevoflurane and isoflurane in humans. Anesth Analg 72:316–324,
1991.
13.
Eger EI II: The effect of inspired concentration
on the rate of rise of alveolar concentration. Anesthesiology 24:153–157,
1963.
14.
Eger EI II: Application of a mathematical model
of gas uptake. In Papper EM, Kitz RJ (eds): Uptake
and Distribution of Anesthetic Agents. New York, McGraw-Hill, 1963, pp 88–103.
15.
Stoelting RK, Eger EI II: An additional explanation
for the second gas effect: A concentrating effect. Anesthesiology 30:273–277,
1969.
16.
Korman B, Mapleson WW: Concentration and second
gas effects: Can the accepted explanation be improved? Br J Anaesth 78:618–625,
1997.
17.
Eger EI II, Smith RA, Koblin DD: The concentration
effect can be mimicked by a decrease in blood solubility. Anesthesiology 49:282–284,
1978.
18.
Epstein RM, Rackow H, Salanitre E, Wolf GL: Influence
of the concentration effect on the uptake of anesthetic mixtures: The second gas
effect. Anesthesiology 25:364–371, 1964.
19.
Taheri S, Eger EI II: A demonstration of the concentration
and second gas effects in humans anesthetized with nitrous oxide and desflurane.
Anesth Analg 89:774–780, 1999.
20.
Stoelting RK, Eger EI II: Percutaneous loss of
nitrous oxide, cyclopropane, ether and halothane in man. Anesthesiology 30:278–283,
1969.
21.
Cullen BF, Eger EI II: Diffusion of nitrous oxide,
cyclopropane, and halothane through human skin and amniotic membrane. Anesthesiology
36:168–173, 1972.
22.
Lockhart SH, Yasuda Y, Peterson N, et al: Comparison
of percutaneous losses of sevoflurane and isoflurane in humans. Anesth Analg 72:212–215,
1991.
23.
Fassoulaki A, Lockhart S, Freire BA, et al: Percutaneous
loss of desflurane, isoflurane and halothane in humans. Anesthesiology 74:479–483,
1991.
24.
Laster MJ, Tahari S, Eger EI II, et al: Visceral
losses of desflurane, isoflurane, and halothane in swine. Anesth Analg 73:209–212,
1991.
25.
Berman ML, Lowe HJ, Hagler KT, Bochantin J: Uptake
and elimination of methoxyflurane as influenced by enzyme induction in the rat.
Anesthesiology 38:352–357, 1973.
26.
Carpenter RL, Eger EI II, Johnson BH, et al: The
extent of metabolism of inhaled anesthetics in humans. Anesthesiology 65:201–205,
1986.
27.
Carpenter RL, Eger EI II, Johnson BH, et al: Pharmacokinetics
of inhaled anesthetics in humans: Measurements during and after the simultaneous
administration of enflurane, halothane, isoflurane, methoxyflurane, and nitrous oxide.
Anesth Analg 65:575–582, 1986.
28.
Carpenter RL, Eger EI II, Johnson BH, et al: Does
the duration of anesthetic administration affect the pharmacokinetics or metabolism
of inhaled anesthetics in humans? Anesth Analg 66:1–8, 1987.
29.
Halsey MJ, Sawyer DC, Eger EI II, et al: Hepatic
metabolism of halothane, methoxyflurane, cyclopropane, Ethrane and Forane in miniature
swine. Anesthesiology 35:43–47, 1971.
30.
Sutton TS, Koblin DD, Gruenke LD, et al: Fluoride
metabolites following prolonged exposure of volunteers and patients to desflurane.
Anesth Analg 73:180–185, 1991.
31.
Sawyer DC, Eger EI II, Bahlman SH, et al: Concentration
dependence of hepatic halothane metabolism. Anesthesiology 34:230–234, 1971.
32.
Eger EI II, Gong D, Koblin DD, et al: Effect of
anesthetic duration on kinetic and recovery characteristics of desflurane vs. sevoflurane
(plus compound A) in volunteers. Anesth Analg 86:414–421, 1998.
33.
Yamamura H, Wakasugi B, Okuma Y, Maki K: The effects
of ventilation on the absorption and elimination of inhalation anaesthetics. Anaesthesia
18:427–438, 1963.
34.
Eger EI II: Ventilation, circulation and uptake.
In Eger EI II (ed): Anesthetic Uptake and Action.
Baltimore, Williams & Wilkins, 1974, pp 122–145.
35.
Fukui Y, Smith NT: Interactions among ventilation,
the circulation, and the uptake and distribution of halothane—Use of a hybrid
computer multiple model. I. The basic model. Anesthesiology 54:107–118, 1981.
36.
Doi M, Ikeda K: Respiratory effects of sevoflurane.
Anesth Analg 66:241–244, 1987.
37.
Fourcade HE, Stevens WC, Larson CP Jr, et al:
The ventilatory effects of Forane, a new inhaled anesthetic. Anesthesiology 35:26–31,
1971.
38.
Munson ES, Larson CP Jr, Babad AA, et al: The
effects of halothane, fluroxene and cyclopropane on ventilation: A comparative study
in man. Anesthesiology 27:716–728, 1966.
39.
Calverley RK, Smith NT, Jones CW, et al: Ventilatory
and cardiovascular effects of enflurane anesthesia during spontaneous ventilation
in man. Anesth Analg 57:610–618, 1978.
40.
Lockhart S, Rampil IJ, Yasuda N, et al: Depression
of ventilation by desflurane in humans. Anesthesiology 74:484–488, 1991.
41.
Gibbons RT, Steffey EP, Eger EI II: The effect
of spontaneous versus controlled ventilation on the rate of rise of alveolar halothane
concentration in dogs. Anesth Analg 56:32–34, 1977.
42.
Yamamura H: The effect of ventilation and blood
volume on the uptake and elimination of inhalation anesthetic agents. In
Progress in Anaesthesiology. Proceedings of the Fourth World Congress of Anesthesiologists.
International Congress Series 200. Amsterdam, Excerpta Medica, 1968, pp 394–399.
43.
Eger EI II, Smith NT, Stoelting RK, et al: Cardiovascular
effects of halothane in man. Anesthesiology 32:396–409, 1970.
44.
Calverley RK, Smith NT, Eger EI II: Cardiovascular
effects of enflurane anesthesia during controlled ventilation in man. Anesth Analg
57:619–628, 1978.
45.
Ebert TJ, Muzi M: Sympathetic hyperactivity during
desflurane anesthesia in healthy volunteers. A comparison with isoflurane. Anesthesiology
79:444–453, 1993.
46.
Weiskopf RB, Moore M, Eger EI II, et al: Rapid
increase in desflurane concentration is associated with greater transient cardiovascular
stimulation than with rapid increase in isoflurane concentration in humans. Anesthesiology
80:1035–1045, 1994.
47.
Eger EI II, Bahlman SH, Munson ES: Effect of age
on the rate of increase of alveolar anesthetic concentration. Anesthesiology 35:365–372,
1971.
48.
Wahrenbrock EA, Eger EI II, Laravuso RB, Maruschak
G: Anesthetic uptake—Of mice and men (and whales). Anesthesiology 40:19–23,
1974.
49.
Salanitre E, Rackow H: The pulmonary exchange
of nitrous oxide and halothane in infants and children. Anesthesiology 30:388–394,
1969.
50.
Gallagher TM, Black GW: Uptake of volatile anaesthetics
in children. Anaesthesia 40:1073–1077, 1985.
51.
Munson ES, Eger EI II, Tham MK, Embro WJ: Increase
in anesthetic uptake, excretion and blood solubility in man after eating. Anesth
Analg 57:224–231, 1978.
52.
Eger EI II, Severinghaus JW: Effect of uneven
pulmonary distribution of blood and gas on induction with inhalation anesthetics.
Anesthesiology 25:620–626, 1964.
53.
Stoelting RK, Longnecker DE: Effect of right-to-left
shunt on rate of increase in arterial anesthetic concentration. Anesthesiology 36:352–356,
1972.
54.
Eger EI II, Saidman LJ: Hazards of nitrous oxide
anesthesia in bowel obstruction and pneumothorax. Anesthesiology 26:61–66,
1965.
55.
Hunter AR: Problems of anaesthesia in artificial
pneumothorax. Proc R Soc Med 48:765–768, 1955.
56.
Munson ES, Merrick HC: Effect of nitrous oxide
on venous air embolism. Anesthesiology 27:783–787, 1966.
57.
Shapiro HM, Yoachim J, Marshall LF: Nitrous oxide
challenge for detection of residual intravascular pulmonary gas following venous
air embolism. Anesth Analg 61:304–306, 1982.
58.
Stanley TH, Kawamura R, Graves C: Effects of nitrous
oxide on volume and pressure of endotracheal tube cuffs. Anesthesiology 41:256–262,
1974.
59.
Kaplan R, Abramowitz MD, Epstein BS: Nitrous oxide
and air-filled balloon-tipped catheters. Anesthesiology 55:71–73, 1981.
60.
Eisenkraft JB, Eger EI II: Nitrous oxide anesthesia
may double the balloon gas volume of Swan-Ganz catheters. Mt Sinai J Med 49:430–433,
1982.
61.
Wolf GL, Capuano C, Hartung J: Nitrous oxide increases
intraocular pressure after intravitreal sulfur hexafluoride injection. Anesthesiology
59:547–548, 1983.
62.
Thomsen KA, Terkildsen K, Arnfred J: Middle ear
pressure variations during anesthesia. Arch Otolaryngol 82:609–611, 1985.
63.
Saidman LJ, Eger EI II: Change in cerebrospinal
fluid pressure during pneumoencephalography under nitrous oxide anesthesia. Anesthesiology
26:67–72, 1965.
64.
Waun JE, Sweitzer RS, Hamilton WK: Effect of nitrous
oxide on middle ear mechanics and hearing acuity. Anesthesiology 28:846–850,
1987.
65.
Graham MD, Knight PR: Atelectatic tympanic membrane
reversal by nitrous oxide supplemented general anesthesia and polyethylene ventilation
tube insertion. A preliminary report. Laryngoscope 41:1469–1471, 1981.
66.
Eger EI II, Larson CP Jr, Severinghaus JW: The
solubility of halothane in rubber, soda lime and various plastics. Anesthesiology
23:356–359, 1962.
67.
Titel JH, Lowe HJ: Rubber-gas partition coefficients.
Anesthesiology 29:1215–1216, 1968.
68.
Targ AG, Yasuda N, Eger EI II: Solubility of I-653,
sevoflurane, isoflurane, and halothane in plastics and rubber composing a conventional
anesthetic circuit. Anesth Analg 68:218–225, 1989.
69.
Eger EI II, Ionescu P, Gong D: Circuit absorption
of halothane, isoflurane and sevoflurane. Anesth Analg 86:1070–1074, 1998.
70.
Eger EI II, Koblin DD, Bowland T, et al: Nephrotoxicity
of sevoflurane vs. desflurane anesthesia in volunteers. Anesth Analg 84:160–168,
1997.
71.
Higuchi H, Sumita S, Wada H, et al: Effects of
sevoflurane and isoflurane on renal function and on possible markers of nephrotoxicity.
Anesthesiology 89:307–322, 1998.
72.
Fang ZX, Eger EI II, Laster MJ, et al: Carbon
monoxide production from degradation of desflurane, enflurane, isoflurane, halothane,
and sevoflurane by soda lime and Baralyme. Anesth Analg 80:1187–1193, 1995.
73.
Eger EI II, Ionescu P, Laster MJ, Weiskopf RB:
Baralyme dehydration increases and soda lime dehydration decreases the concentration
of compound A resulting from sevoflurane degradation in a standard anesthetic circuit.
Anesth Analg 85:892–898, 1997.
74.
Harper M, Eger EI II: A comparison of the efficiency
of three anesthesia circle systems. Anesth Analg 55:724–729, 1976.
75.
Sharp JH, Trudell JR, Cohen EN: Volatile metabolites
and decomposition products of halothane in man. Anesthesiology 50:2–8, 1979.
76.
Morio M, Fujii K, Satoh N, et al: Reaction of
sevoflurane and its degradation products with soda lime. Toxicity of the byproducts.
Anesthesiology 77:1155–1164, 1992.
77.
Severinghaus JW: The rate of uptake of nitrous
oxide in man. J Clin Invest 33:1183–1189, 1954.
78.
Lowe HJ, Ernst EA: The Quantitative Practice of
Anesthesia. Use of Closed Circuit. Baltimore, Williams & Wilkins, 1981, pp
1–234.
79.
Titel JH, Lowe HJ, Elam JO, Grosholz JR: Quantitative
closed-circuit halothane anesthesia. Anesth Analg 47:560–569, 1968.
80.
Hendrickx JFA, Soetens M, VanderDonck A, et al:
Uptake of desflurane and isoflurane during closed-circuit anesthesia with spontaneous
and controlled mechanical ventilation. Anesth Analg 84:413–418, 1997.
81.
Eger EI II: Complexities overlooked: Things may
not be what they seem. Anesth Analg 84:239–240, 1997.
82.
Eger EI II: Desflurane (Suprane). A Compendium
and Reference. Rutherford, NJ, Healthpress Publishing Group, 1993, pp 1–119.
83.
Weiskopf RB, Eger EI II: Comparing the costs of
inhaled anesthetics. Anesthesiology 79:1413–1418, 1993.
84.
Eger EI II, Johnson BH: Rates of awakening from
anesthesia with I-653, halothane, isoflurane, and sevoflurane: A test of the effect
of anesthetic concentration and duration in rats. Anesth Analg 66:977–982,
1987.
85.
Mapleson WW: Quantitative prediction of anesthetic
concentrations. In Papper EM, Kitz RJ (eds): Uptake
and Distribution of Anesthetic Agents. New York, McGraw-Hill, 1963, pp 104–119.
86.
Stoelting RK, Eger EI II: The effects of ventilation
and anesthetic solubility on recovery from anesthesia: An in vivo and analog analysis
before and after equilibration. Anesthesiology 30:290–296, 1969.
87.
Bailey JM: Context-sensitive half-times and other
decrement times of inhaled anesthetics. Anesth Analg 85:681–686, 1997.
88.
Stoelting RK, Longnecker DE, Eger EI II: Minimal
alveolar concentrations on awakening from methoxyflurane, halothane, ether and fluorxene
in man: MAC awake. Anesthesiology 33:5–9, 1970.
89.
Dwyer R, Bennett HL, Eger EI II, Heilbron D: Effects
of isoflurane and nitrous oxide in subanesthetic concentrations on memory and responsiveness
in volunteers. Anesthesiology 77:888–898, 1992.
90.
Katoh T, Suguro Y, Nakajima R, et al: Blood concentration
of sevoflurane and isoflurane on recovery from anaesthesia. Br J Anaesth 69:259–262,
1992.
91.
Katoh T, Suguro Y, Ikeda T, et al: Influence of
age on awakening concentrations of sevoflurane and isoflurane. Anesth Analg 76:348–352,
1993.
92.
Chortkoff BS, Eger EI II, Crankshaw DP, et al:
Concentrations of desflurane and propofol that suppress response to command in humans.
Anesth Analg 81:737–743, 1995.
93.
Neumann MA, Weiskopf RB, Gong DH, et al: Changing
from isoflurane to desflurane towards the end of anesthesia does not accelerate recovery
in humans. Anesthesiology 88:914–921, 1998.
94.
Rehder K, Forbes J, Alter H, et al: Halothane
biotransformation in man: A quantitative study. Anesthesiology 28:711–715,
1967.
95.
Chase RE, Holaday DA, Fiserova-Bergerova V, et
al: The biotransformation of Ethrane in man. Anesthesiology 35:262–267, 1971.
96.
Fink BR: Diffusion anoxia. Anesthesiology 16:511–519,
1955.
97.
Sheffer L, Steffenson JL, Birch AA: Nitrous oxide-induced
diffusion hypoxia in patients breathing spontaneously. Anesthesiology 37:436–439,
1972.
98.
Rackow H, Salanitre E, Frumin MJ: Dilution of
alveolar gases during nitrous oxide excretion in man. J Appl Physiol 16:723–728,
1961.
99.
Eger EI II: Effect of anesthetic circuit on alveolar
rate of rise. In Eger EI II (ed): Anesthetic Uptake
and Action. Baltimore, Williams & Wilkins, 1974, pp 192–205.
100.
Eger EI II, Brandstater B: Solubility of methoxyflurane
in rubber. Anesthesiology 24:679–683, 1963.
101.
Munson ES, Eger EI II: Methoxyflurane solubility
in plastics. Anesthesiology 26:828, 1965.
